Atricure Inc’s filing revealed that its Director GROVES REGINA E unloaded Company’s shares for reported $90283.0 on Aug 06 ’25. In the deal valued at $36.82 per share,2,452 shares were sold. As a result of this transaction, GROVES REGINA E now holds 33,715 shares worth roughly $1.21 million.
Then, Doraiswamy Vinayak sold 2,500 shares, generating $91,450 in total proceeds. Upon selling the shares at $36.58, the Chief Scientific Officer now owns 71,872 shares.
Before that, GROVES REGINA E bought 2,452 shares. Atricure Inc shares valued at $90,307 were divested by the Director at a price of $36.83 per share.
A number of analysts have revised their coverage, including Oppenheimer’s analysts, who increased its forecast for the stock in late April from “a Perform” to “an Outperform”. JMP Securities began covering ATRC with “Mkt outperform” recommendation on October 23, 2023. UBS started covering the stock on September 29, 2023. It rated ATRC as “a Buy”.
Price Performance Review of ATRC
On Tuesday, Atricure Inc [NASDAQ:ATRC] saw its stock jump 0.97% to $35.84. Over the last five days, the stock has lost -4.53%. Atricure Inc shares have risen nearly 66.78% since the year began. Nevertheless, the stocks have risen 17.28% over the past one year. While a 52-week high of $43.11 was reached on 01/29/25, a 52-week low of $20.70 was recorded on 05/01/25.
Levels Of Support And Resistance For ATRC Stock
The 24-hour chart illustrates a support level at 35.21, which if violated will result in even more drops to 34.59. On the upside, there is a resistance level at 36.27. A further resistance level may holdings at 36.71.
How much short interest is there in Atricure Inc?
A steep rise in short interest was recorded in Atricure Inc stocks on 2025-07-31, growing by 0.68 million shares to a total of 2.22 million shares. Yahoo Finance data shows the prior-month short interest on 2025-06-30 was 1.55 million shares. There was a rise of 30.48%, which implies that there is a positive sentiment for the stock.
